QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 small-caps-bitcoin-rally-as-traders-await-fed-rate-cut-treasury-yields-us-dollar-tick-up-on-strong-retail-sales-whats-driving-markets-tuesday

Wall Street experienced a slightly positive session Tuesday, supported by investor optimism as the Federal Open Market Committe...

 whats-going-on-with-moderna-shares-tuesday

Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 vaccine.

 moderna-gets-health-canada-approval-for-updated-covid-19-vax

- Bloomberg

 desantis-administration-cautions-against-pfizer-moderna-mrna-covid-vaccines-for-vulnerable-individuals-cites-concerns-related-to-rare-heart-conditions

Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration...

 goldman-sachs-maintains-buy-on-moderna-lowers-price-target-to-139

Goldman Sachs analyst Salveen Richter maintains Moderna (NASDAQ:MRNA) with a Buy and lowers the price target from $178 to $139.

 barclays-maintains-overweight-on-moderna-lowers-price-target-to-125

Barclays analyst Gena Wang maintains Moderna (NASDAQ:MRNA) with a Overweight and lowers the price target from $155 to $125.

Core News & Articles

- Bloomberg

 moderna-tyson-foods-and-adobe-are-among-top-10-large-cap-stock-losers-last-week-sep-8-sep-14-are-the-others-in-your-portfolio

10 worst performing large-cap stocks last week: RTO, ALLY, MRNA, HUM, TSN, BEKE, ADBE, RYAAY, JPM, DVN. Consider impact on your...

 moderna-faces-analyst-downgrades-amid-revised-rd-restructured-strategy-and-delayed-profitability-target

Moderna announces plans to reduce R&D spending by $1.1 billion by 2027, focusing on ten key products. Analysts highlight ne...

Core News & Articles

https://www.nbcnews.com/health/health-news/florida-covid-shots-mrna-vaccines-older-adults-rcna170997Even as the Covid wave in F...

 b-of-a-securities-maintains-neutral-on-moderna-lowers-price-target-to-110

B of A Securities analyst Geoff Meacham maintains Moderna (NASDAQ:MRNA) with a Neutral and lowers the price target from $130...

 td-cowen-maintains-hold-on-moderna-lowers-price-target-to-60

TD Cowen analyst Tyler Van Buren maintains Moderna (NASDAQ:MRNA) with a Hold and lowers the price target from $70 to $60.

 rbc-capital-maintains-sector-perform-on-moderna-lowers-price-target-to-75

RBC Capital analyst Luca Issi maintains Moderna (NASDAQ:MRNA) with a Sector Perform and lowers the price target from $90 to ...

 jp-morgan-downgrades-moderna-to-underweight-lowers-price-target-to-70

JP Morgan analyst Jessica Fye downgrades Moderna (NASDAQ:MRNA) from Neutral to Underweight and lowers the price target from ...

 jefferies-downgrades-moderna-to-hold-lowers-price-target-to-65

Jefferies analyst Michael Yee downgrades Moderna (NASDAQ:MRNA) from Buy to Hold and lowers the price target from $120 to $65.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION